Becoming a psychedelic therapist requires a clinical license (MD, NP, psychologist, LCSW, or similar) plus specialized training — unless you pursue the Oregon Measure 109 lay-facilitator route, which does not require a clinical license.
Becoming a psychedelic therapist is possible today — but the path depends heavily on what state you live in and what license you already hold. This guide lays out every major route: clinical licensing tracks, formal training programs, and the non-clinical Oregon and Colorado facilitator paths that many guides miss entirely.
New to the field? Start with our explainer on what psychedelic therapy is before working through the licensing requirements below.
Most psychedelic therapy roles today require either a clinical mental health or medical license plus a specialized training program, or completion of an OHA-approved facilitator program in Oregon (no clinical license required). For ketamine-assisted therapy in any state, you need a clinical license — at minimum an LCSW, LPC, MFT, or psychologist credential, working alongside a prescribing physician. For psilocybin, legal paid work currently exists only in Oregon and Colorado, where state-regulated facilitator programs open the door to people without clinical degrees.
The licenses that qualify depend on what you want to do — prescribe, provide therapy, or facilitate a session — and which state you work in.
Physicians (MD/DO), nurse practitioners (NP), and physician assistants (PA) can prescribe ketamine anywhere in the United States. This makes them the backbone of ketamine clinic operations. Many prescribers hire therapists to handle the therapeutic component while they manage medical screening, dosing, and safety monitoring. A prescriber who also wants to deliver the psychotherapy directly will need additional psychedelic-specific training from a program like CIIS or the Ketamine Training Center (see below).
Licensed psychologists, clinical social workers (LCSW), marriage and family therapists (MFT), and licensed professional counselors (LPC) can provide the therapy component of psychedelic-assisted treatment — but they cannot prescribe. In a ketamine clinic setting, the licensed therapist works under a physician or NP who handles prescribing. Can an LCSW do psychedelic therapy? Yes — under physician supervision for ketamine, or as an Oregon-approved facilitator for psilocybin. These clinicians are in high demand because they have the clinical hours and ethics training that psychedelic work requires. To move into this field, they add a specialized training program to their existing license rather than starting from scratch.
LCSWs and MFTs interested in integration therapy can practice that work in most states without any additional license, since integration does not involve administering a substance.
Registered nurses (RN) play a growing role in ketamine clinics, primarily in monitoring and facilitation during infusion sessions. RNs cannot prescribe ketamine independently, but they often make up the majority of clinical staff in busy infusion centers. An RN who wants to run sessions rather than just monitor vital signs will benefit from a psychedelic facilitation training. Oregon also allows RNs to qualify as licensed facilitators through the standard OHA-approved training track (see the Oregon section below).
This is the route most guides miss. Oregon Measure 109 created a legal category called "psilocybin facilitator" that does not require any clinical license. Any adult who completes an OHA-approved training program, passes a background check, and meets the supervised-hours requirement can apply for a facilitator license. This opens the door for coaches, chaplains, social workers, and others who do not hold a clinical therapy license. Colorado's Proposition 122 is building a similar framework. If you do not have a clinical background and want to work legally with psychedelics now, the Oregon facilitator track is your clearest current path.
No single training program is required by law outside of Oregon and Colorado. But clinicians who want to practice ketamine-assisted therapy are expected by professional bodies and malpractice insurers to complete a structured psychedelic training. The programs below are among the most recognized as of 2026.
CIIS offers a Certificate in Psychedelic-Assisted Therapies and Research, one of the longest-running formal programs in the field. The program runs roughly nine months and costs approximately $10,000. It covers MDMA-assisted therapy, psilocybin-assisted therapy, and ketamine-assisted therapy, and includes supervised practicum hours. CIIS is a regionally accredited graduate institution, which gives the certificate weight with employers and licensing boards. Applicants typically need a master's degree in a mental health field or equivalent clinical experience.
Fluence focuses on ketamine-assisted therapy and IFS (Internal Family Systems)-informed psychedelic work. Programs range from approximately $3,000 for shorter intensive trainings to around $7,000 for longer certificate tracks. Fluence is particularly popular with LCSWs and LPCs who want practical ketamine therapy skills without a nine-month commitment. Training is largely online with in-person intensive components.
Naropa offers a graduate-level Contemplative Psychotherapy and Buddhist Psychology program with psychedelic therapy elective tracks. This is a full degree program (MA), not a short certificate. It suits applicants who want a primary mental health license and psychedelic specialization in one program rather than adding a certificate to an existing degree.
MAPS (Multidisciplinary Association for Psychedelic Studies) trained therapists for its Phase 3 MDMA-assisted therapy trials. As of 2026, the MAPS training pipeline for new enrollees is paused following the FDA's 2024 Complete Response Letter for MDMA. The training may reopen if MDMA receives future FDA approval or as MAPS restructures its clinical programs. Monitor MAPS.org for updates if MDMA-assisted therapy is your focus.
The Ketamine Training Center (KTC) offers short-format, clinician-facing training for MDs, NPs, PAs, and therapists who want to add ketamine services to an existing practice. Programs run from one to several days with costs in the $1,500–$3,500 range. KTC is best suited for clinicians who already have a strong clinical foundation and want operational and safety training specific to ketamine infusion or lozenge protocols.
ATMA, based in Canada, offers a psychedelic therapy training program open to licensed mental health professionals. Given Canadian legal frameworks, some content differs from US practice. US-based clinicians attend for the therapeutic approach training — ATMA has worked with psilocybin and ketamine frameworks. Costs and availability vary by cohort. Verify US applicability with the program before enrolling.
The table below summarizes the six programs above across the dimensions most relevant to a clinician or aspiring facilitator choosing a program. Costs are approximate and subject to change — verify directly with each program.
| Program | Format | Duration | Approx. cost | Clinical license required? | Best for |
|---|---|---|---|---|---|
| CIIS Certificate | Hybrid (online + in-person) | ~9 months | ~$10,000 | Yes (master's-level or equivalent) | Comprehensive multi-substance training; academic credential |
| Fluence | Largely online; in-person intensives | Weeks–months (varies by track) | $3,000–$7,000 | Yes (licensed clinician) | LCSWs/LPCs adding ketamine; IFS-informed approach |
| Naropa (MA) | Residential graduate degree | 2–3 years | Full graduate tuition | No (degree grants licensure path) | Primary degree + psychedelic specialization in one program |
| MAPS MDMA Training | Intensive (cohort-based) | Multi-day intensives | Varies (paused as of 2026) | Yes | MDMA-assisted therapy focus; trial-protocol fidelity |
| Ketamine Training Center | Short intensive (in-person) | 1–3 days | $1,500–$3,500 | Yes (MD, NP, PA, or therapist) | Rapid operational upskill for existing clinicians |
| ATMA Journey Centers | Cohort-based (Canada-based) | Varies by cohort | Varies; verify directly | Yes (licensed mental health professional) | Canadian practitioners; therapeutic approach training |
For non-clinicians without a mental health license, the Oregon OHA facilitator pathway below is the only currently available US legal route — no clinical license is required, but the OHA-approved training and licensing process is mandatory.
Oregon created the first US state-regulated psilocybin facilitator program under Measure 109, administered by the Oregon Health Authority (OHA). This is the clearest legal pathway for someone without a clinical license who wants to work with psilocybin today.
To become a licensed Oregon psilocybin facilitator, you must:
No clinical degree — no therapy license, no nursing license, no medical degree — is required. Oregon explicitly designed this to allow trained non-clinicians to facilitate legal psilocybin sessions at licensed service centers. This is the single biggest information gap in most "psychedelic therapist" guides online: the Oregon route is a real, legal, operational pathway right now.
Cost range: OHA-approved training programs vary widely. Budget $3,000 on the low end for shorter programs and $15,000 or more for longer immersive formats with extensive practicum hours. The Oregon facilitator license itself costs several hundred dollars in state fees.
Where you can work after licensing: Oregon only. A facilitator license issued by OHA is not recognized in other states. You must work at an OHA-licensed psilocybin service center. You cannot facilitate sessions independently or in private homes.
For more on Oregon's program structure, see the OHA Oregon Psilocybin Services page.
Colorado Proposition 122, passed in November 2022, legalized supervised natural medicine use including psilocybin and other plant medicines. The Colorado Department of Regulatory Agencies (DORA) is building the facilitator licensing framework, with the program expected to be fully operational in 2026.
Like Oregon, Colorado's framework is designed to include both clinical and non-clinical facilitators, with state-approved training as the gateway. The structure differs from Oregon in scope — Colorado's Proposition 122 covers a broader list of natural medicines beyond psilocybin, including DMT, mescaline (non-peyote), and ibogaine.
If you are planning a career in this space, monitor Colorado DORA's natural medicine page for approved training programs as they are announced. Early movers who complete Oregon training first are positioning themselves to transition into Colorado licensing once requirements are finalized.
The psychedelic therapy job market is real but small, concentrated, and highly dependent on your license and location. Here is an honest look at where the roles are.
Ketamine clinics are currently the largest employer of psychedelic-adjacent clinical staff in the US. Most positions are for RNs (who monitor infusion sessions) and NPs or PAs (who handle prescribing). LCSWs and therapists are hired in clinics that offer a therapy-integrated model — typically a smaller subset of all ketamine providers. Salary ranges for ketamine clinic roles:
These figures are directional, not guarantees. Compensation varies significantly by city, clinic size, and model. The Psychedelic Journal is an educational resource, not a job board.
Oregon service centers hire licensed facilitators. The market is still small — Oregon had fewer than 50 licensed service centers operating statewide in early 2026. Many facilitators are independent contractors rather than full-time employees. Colorado's market will grow as DORA licensing comes online.
Clinical trials offer another entry point, especially for clinicians. Research therapist and clinical coordinator roles are posted on ClinicalTrials.gov (search our tool here) and through organizations like MAPS, the Heffter Research Institute, and university research centers. These roles require clinical credentials and often pay on academic or non-profit salary scales.
Licensed therapists can build an integration therapy practice without administering any substance — working with clients before and after psychedelic experiences to help them process insights. This is legal in every state for licensed therapists today and is one of the fastest-growing areas of demand as more people seek legal and underground psychedelic experiences. See our psychedelic therapist finder to get a sense of what practitioners in this space offer.
Not sure which path fits your goals? Our which psychedelic quiz can help you think through the landscape.
How long it takes depends almost entirely on where you are starting from. Here are realistic timelines for the most common starting points.
Completing medical school and a psychiatry or primary care residency takes 12 or more years from the start of undergraduate education. Once licensed, adding a psychedelic therapy training program like CIIS or the Ketamine Training Center takes 9 months to 1 year. If you already have your MD and license, add the training program on top.
Getting an LCSW typically takes a bachelor's degree (4 years), a master's in social work or counseling (2 years), and 2 years of post-degree supervised clinical experience before licensure. Total: 8 or more years from the start of college. After licensure, add a psychedelic training program (3 months to 1 year depending on format). If you already hold an LCSW or LPC, you can begin a training program immediately and be practicing ketamine-assisted therapy within a year of starting that training.
The Oregon facilitator path is the fastest route to legal psychedelic facilitation work for someone without a clinical background. Most OHA-approved training programs run 9 months. After completing training and supervised hours, you apply for an OHA facilitator license. Realistically, plan for 12–18 months from program start to first licensed session, including application processing time. You must then work in Oregon at a licensed service center.
If you are already an RN in a ketamine setting, you have the fastest route to expanded psychedelic facilitation practice. Adding a training program (3–12 months) and, if desired, an Oregon facilitator license positions you well as the market grows.
Salary expectations vary sharply across the psychedelic-therapy career tracks. The generic ranges below reflect what practitioners have actually reported through 2026 — not what training providers advertise.
KAP therapists most commonly work as independent contractors alongside a prescribing MD or NP, split-fee or per-session. Cash-pay KAP sessions typically bill $250–$600 for a 2–3 hour dosing session and $150–$250 for a 60–90 minute integration session. In practice, a full-time KAP therapist netting $90,000–$160,000 is a realistic 2026 range; a part-time supplement to a general psychotherapy practice runs $20,000–$60,000. For the KAP-specific pathway see how to become a ketamine therapist.
Licensed facilitators in Oregon typically charge $150–$400 per hour of facilitation time, and a full psilocybin session runs 6–8 hours. Reported 2026 gross earnings range widely — $30,000–$90,000 for full-time facilitators — because session volume in Oregon service centers is still building. Many facilitators work part-time and supplement with another income. For the full certification path see psilocybin facilitator certification in Oregon.
Because MDMA is not FDA-approved, most trained MDMA therapists earn income through the sponsor-affiliated trials, expanded-access, and VA-partnered studies. Sponsored-study stipends range roughly $80,000–$150,000 depending on cohort size, location, and time commitment. Post-approval market pay will depend on the eventual REMS network. For the training map see MDMA therapist training programs.
For non-therapist tracks the 2026 salary picture is clearer. Clinical research coordinators earn $50,000–$80,000, protocol nurses $85,000–$120,000, CRNAs in ketamine clinics $180,000–$230,000, and biostatisticians $110,000–$160,000. Deep dives: psychedelic research jobs and psychedelic nurse jobs.
A part-time reality dominates the psychedelic-therapy market outside research settings. Very few practitioners earn their full living from psychedelic work alone; most blend it with a general psychotherapy or medical practice. Job listings that promise $200,000+ from KAP-only practice are almost always growth projections, not typical current pay.
It depends on the substance and state. For ketamine-assisted therapy anywhere in the US, a prescribing license (MD, DO, NP, PA) or a clinical therapy license (psychologist, LCSW, MFT) under physician supervision is required. For psilocybin facilitation, Oregon's Measure 109 created a lay-facilitator track that does not require a clinical license — applicants complete an Oregon Health Authority-approved training program instead. Colorado's Proposition 122 has a similar facilitator pathway.
Yes, in most cases. Licensed clinical social workers can provide ketamine-assisted therapy under physician supervision at a clinic that employs or contracts with a prescribing clinician. They can also pursue Oregon or Colorado psilocybin facilitator approval independently. LCSWs cannot prescribe ketamine themselves; the prescription must come from an MD, DO, NP, or PA.
The California Institute of Integral Studies (CIIS) offers a Certificate in Psychedelic-Assisted Therapies (roughly $10,000, nine months). Fluence provides IFS and ketamine-assisted training programs ($3,000 to $7,000). Naropa University has a graduate-level track. The MAPS MDMA-therapy training is currently paused for new enrollees pending the FDA review process. The Oregon Health Authority maintains a list of OHA-approved programs for Measure 109 facilitators.
The field is small and salaries vary widely. Registered nurses working at ketamine clinics typically earn $70,000 to $90,000 per year. Clinic directors or senior NPs can earn $80,000 to $120,000. Oregon psilocybin facilitators working independently set their own rates — session fees at licensed service centers commonly run $1,000 to $3,500, with facilitators keeping a negotiated portion. Integration therapists in private practice typically charge standard therapy rates ($150 to $300 per session).
It depends heavily on your starting point. A physician adds psychedelic training after 12 or more years of education and residency. An LCSW adds training after six or more years of school and two years of supervised practice. The Oregon lay-facilitator route is the fastest standalone path: an OHA-approved training program (typically nine to twelve months) plus OHA licensure, with no prior clinical degree required.
Get psychedelic research & policy updates
New trials, FDA decisions, and legal changes for psychedelic — delivered when they happen.
Suggest a tool, topic, or improvement that would make this site more useful.